Concepedia

Kua Liu

KL

Statistics

Publications

4

Citations

85

H-Index

4

Active since

2023

Affiliations

Nanjing University(Current)

Central South University

Jinan Stomatological Hospital

Nanjing Drum Tower Hospital

Nanjing Medical University

Kua Liu is an author at Nanjing University specializing in triple-negative breast cancer therapy, cancer cell proliferation inhibition, and g1 cell-cycle arrest.

Publications per year

2023–2025

4

Publications

4

Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy

Kua Liu, Lingkai Kong, Huawei Cui et al. · Cell Reports Medicine · 2024 · 44 citations · Full text

, , +17

SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy

Peng Hui Wang, Jiannan Qiu, Yuan Fang et al. · Cell Death and Differentiation · 2025 · 18 citations · Full text

, , +17

MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway

Ding Ma, Shuwen Liu, Kua Liu et al. · Cancer Biology & Therapy · 2024 · 12 citations · Full text

, , +15

Ezetimibe inhibits triple-negative breast cancer proliferation and promotes cell cycle arrest by targeting the PDGFR/AKT pathway

Qinyu He, Lingkai Kong, Weiwei Shi et al. · Heliyon · 2023 · 11 citations · Full text

, , +17

1–4 of 4